Article 754HF Former NFL TE Greg Olsen is helping fight the stigma of prostate cancer screenings

Former NFL TE Greg Olsen is helping fight the stigma of prostate cancer screenings

by
from on (#754HF)
75f03db96546f884246f160d50e95176NEW ORLEANS, LOUISIANA - FEBRUARY 06: Greg Olsen speaks on radio row prior to Super Bowl LIX at the Ernest Morial Convention Center on February 06, 2025 in New Orleans, Louisiana. (Photo by Aaron J. Thornton/Getty Images) | Getty Images

Everyone understands.

The stigma around getting tested for prostate cancer is not great. Many men avoid getting tested for this reason, which is dangerous given that 1 in 8 people with a prostate will be diagnosed with prostate cancer in their lifetime. Early detection saves lives, though. The 5-year survival rate, if prostate cancer is detected early, is over 99%. Think about that.

This is why what Novartis is doing is so important. They have a method for testing that is a blood test and a campaign involving star NFL tight ends to help promote it. The players caution people to relax" because it's a blood test and Greg Olsen is among those doing so.

Again, screening here can begin with a simple PSA blood test which is important information for people to have. Olsen and his fellow tight ends are doing what they can to help people experiencing the NFL draft in Pittsburgh to understand this. There will be interactive and onsite fan activations in Pittsburgh this week as well.

Olsen also spoke about modern happenings in the NFL and I had to press him about the Dallas Cowboys given that he winds up calling so many of their games. He noted that the team has had quite the circular pattern over the last four or so years and that they are still trying to find stable ground. Perhaps that can happen this week at the draft.

Our thanks to Olsen for the time and to Novartis for the awareness.

External Content
Source RSS or Atom Feed
Feed Location http://sports.yahoo.com/nfl/rss.xml
Feed Title
Feed Link https://sports.yahoo.com/nfl/
Feed Copyright Copyright (c) 2026 Yahoo! Inc. All rights reserved.
Reply 0 comments